Australian Genomics inviting expressions of interest for new rare disease flagships.
Australian Genomics is now inviting expressions of interest for new Rare Disease Flagship projects, to commence in 2018 and run for two years.
Australian Genomics has implemented a program of research to demonstrate how the application of genomic data impacts the care of patients across a range of disorders. Our clinical flagships are central to this research model: they are nationally coordinated projects, founded in clinical practice, driving data through our programs to enable real-time evaluation of the impact of genomics on patient care.
Applications for Rare Disease Flagships (2018 – 2020) are now open and will close 30 September 2017.
For more information or a copy of the application form, please contact Tiffany Boughtwood (Tiffany.Boughtwood@mcri.edu.au / 03 9936 6321).